Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure

Angiology

Volumn 64, Issue 4, 2013, Pages 300-303

  Tekin, Gulacan ^a   Tekin, Yusuf Kenan ^b   Erbay, Ali Riza ^a   Turhan, Hasan ^c   Yetkin, Ertan ^d  

^a BOZOK UNIVERSITY   (Turkey)

^b Yozgat State Hospital   (Turkey)

^c Gozde Hospital   (Turkey)

^d Ortadogu Hospital   (Turkey)

Author keywords

atrial fibrillation; heart failure; uric acid

Indexed keywords

URIC ACID;

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SINUS RHYTHM; URIC ACID BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; UP-REGULATION; URIC ACID; VENTRICULAR FUNCTION, LEFT;

EID: 84875934748     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712448247     Document Type: Article

References (20)

1. Duan X, Ling F. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?. Med Hypotheses. 2008 ; 70 (3). 578-581
2. Tamariz L, Agarwal S, Soliman EZ, et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] Study). Am J Cardiol. 2011 ; 108 (9). 1272-1276
3. Liese AD, Hense HW, Löwel H, Döring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology. 1999 ; 10 (4). 391-397
4. Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004 ; 65 (3). 1041-1049
5. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003 ; 107 (15). 1991-1997
6. Weimert NA, Tanke WF, Sims JJ. Allopurinol as a cardioprotectant during coronary artery bypass graft surgery. AnnPharmacother. 2003 ; 37 (11). 1708-1711
7. Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001 ; 104 (20). 2407-2411
8. Struthers AD, Donnan PT, Lindsay P, McNaughton D, Broomhall J, Macdonald TM. Effect of allopurinol on mortality and hospitalizations in congestive heart failure: a retrospective cohort study. Heart. 2002 ; 87 (3). 229-234
9. Liu T, Zhang X, Korantzopoulos P, Wang S, Li G. Uric acid levels and atrial fibrillation in hypertensive patients. Intern Med. 2011 ; 50 (8). 799-803
10. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007 ; 115 (2). 135-143
11. Leyva F, Anker SD, Godsland IF, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1998 ; 19 (12). 1814-1822
12. Letsas KP, Korantzopoulos P, Filippatos GS, et al. Uric acid elevation in atrial fibrillation. Hellenic J Cardiol. 2010 ; 51 (3). 209-213
13. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008 ; 392 (1-2). 1-7
14. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis. 2009 ; 202 (1). 11-17
15. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008 ; 51 (1). 1-11
16. Shimano M, Shibata R, Inden Y, et al. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm. 2009 ; 6 (7). 935-940
17. Athyros VG, Elisaf M, Papageorgiou AA, et al. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart- disease Evaluation (GREACE) Study. Am J Kidney Dis. 2004 ; 43 (4). 589-599
18. Nath SD, Voruganti VS, Arar NH, et al. Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol. 2007 ; 18 (12). 3156-3163
19. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008 ; 359: 1811-1821
20. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001 ; 37 (2). 371-378